Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25054a6274b6d93c229368ec7e4bbf28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8fda49edd72ac26b4ac81121dfd1923 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d33e45e5cbd64b8b893bd62ee22a85b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-531 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-1138 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44fde8d65c5f58be55ebd4f83531dff1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_588ae2e1f287e9817e8a0d81382e1c4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a573facd7a1372aaee283e79243456 |
publicationDate |
2017-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2017183662-A1 |
titleOfInvention |
Methods and Compositions for Treating Neuropathic Pain |
abstract |
The present invention relates to an inhibitor of FXYD2 gene expression for use in a method for treating neuropathic pain in a patient in need thereof. The invention also relates to a pharmaceutical composition comprising an inhibitor of FXYD2 gene expression, wherein said pharmaceutical composition is formulated for a direct administration into the peripheral nervous system (PNS) of a patient (e.g., formulated for intrathecal administration). |
priorityDate |
2014-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |